• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Edwards’ Q3 sales rise 18 percent, profits jump 8 percent | Earnings Roundup

Edwards’ Q3 sales rise 18 percent, profits jump 8 percent | Earnings Roundup

October 19, 2011 By MassDevice staff

Edwards Lifesciences

Edwards Lifesciences (NYSE:EW) can’t seem to get a break on Wall Street, where its share price slipped 3.4 percent today despite growth for its top and bottom lines.

The Irvine, Calif.-based heart valve maker missed The Street’s earnings forecast by a mere penny, but that was enough to send its shares down to a $67.79 close.

That despite reporting profits of $52 million, or 43 cents per diluted share, on sales of $413 million for the three months ended Sept. 30. That’s a bottom-line boost of 7.5 percent and a top-line increase of 18.3 percent compared with profits of $48 million, or 40 cents diluted EPS, on sales of $349 million during the same period last year.

Sign up to get our free newsletters delivered right to your inbox

Excluding special items adjusted EPS was 38 cents, "primarily driven by the expected U.S. Sapien launch investments and the impact of foreign exchange," according to a press release. Analysts were looking for adjusted EPS of 39 cents, according to MarketWatch.

"On our fourth anniversary of commercial sales outside the U.S., it is gratifying to see our transcatheter heart valves addressing the large unmet patient need and driving strong growth. And the FDA approval, which we expect any day, will allow Sapien to reach many inoperable patients in the U.S. suffering from severe aortic stenosis," chairman & CEO Michael Mussallem said in prepared remarks.

Mussallem said Edwards expects full-year sales to be between $1.68 billion and $1.72 billion, with adjusted EPS of 57 cents to 62 cents.

"While even a minor shift in timing of the U.S. approval of Sapien affects the fourth quarter earnings, the value to Edwards in 2012 and beyond remains compelling," he added.

MassDevice.com Earnings Roundup

MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.

ICU Medical’s Q3 sales stay flat, profits tick up

ICU Medical Inc., (NSDQ:ICUI) posted profits of $9.3 million, or 65 cents oer diluted share, on sales of $76.5 million for the three months ended Sept. 30.

That compares with profits of $9.0 million, also 65 cents diluted EPS, on sales of $75.7 million during Q3 2010. Read more

Cantel Medical’s Q4, FY2011 sales & earnings rise

Cantel Medical (NYSE:CMN) posted sales and earnings increases for its fiscal fourth quarter and FY2011.

The Little Falls, N.J.-based medical device maker reported fourth-quarter profits of $4.7 million, or 27 cents EPS, on sales of $86.0 million during the three months ended July 31. That compares with profits of $4.6 million, also 27 cents EPS, on sales of $69.8 million during Q4 2010.

For the full year, Cantel reported profits of $20.4 million, or $1.18 EPS, on sales of $321.7 million. That compares with profits of $19.9 million, also $1.18 EPS, on sales of $274.0 million. Read more

Synergetics surges in Q4 but full-year profits dip

Synergetics USA Inc. (NSDQ:SURG) more than doubled its fourth-quarter profits, but a bottom-line increase for its full fiscal year eluded the O’Fallon, Mo.-based medical device maker.

Fourth-quarter net income was $2.0 million, or 8 cents EPS, on sales of $15.8 million for the three months ended July 31. That compares with profits of $1.0 million, or 4 cents EPS, on sales of $13.1 million during the same period last year.

For the full year, Synergetics logged profits of $5.6 million, or 23 cents EPS, on sales of $55.8 million, a bottom-line slip of 1.7 percent compared with profits of $5.7 million, also 23 cents EPS, on sales of $52.1 million. Read more

Filed Under: MassDevice Earnings Roundup, News Well, Replacement Heart Valves, Wall Street Beat Tagged With: Cantel Medical Corp., Edwards Lifesciences, ICU Medical Inc., Q3, Synergetics USA Inc.

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy